LCLAT1 and fatty liver disease: In models of obesity, fatty liver disease, and myocardial infarction, upregulated LCLAT1 expression and subsequent CL remodeling resulted in the downregulation of ETC complexes, increased ROS production, activation of hypoxia-responsive signaling pathways, aberrant crista formation, and mitochondrial dysfunction.48